biomarker validation
MD Anderson, BostonGene Ink Collaboration to Develop Cancer Diagnostics
The partners will validate therapeutically actionable cancer biomarker targets and develop multiple tests from this research.
Researchers Find Keratin 17 Biomarker Shows Promise as Diagnostic Indicator for Bladder Cancer
Premium
The biomarker can detect both aggressive and low-grade forms of bladder cancer, and a test for the biomarker has been licensed by KDx Diagnostics.
Valted Seq Lands Exclusive Rights to Evaluate Johns Hopkins Neurodegenerative Disease Dx Assays
The biomarker assays could one day be used as companion diagnostics for new treatments of Parkinson's and related diseases.
Thermo Fisher, Janssen Biotech to Develop CDx for Lung Cancer, Other Indications
The companies initially plan to validate biomarkers for use with the Oncomine Dx Target Test to identify NSCLC patients for enrollment into clinical trials.
The company announced during its Q4 earnings call that it had acquired Paradigm Diagnostics and Viomics to fill out its expertise in cancer diagnostics.
Nov 19, 2019
Oct 30, 2019
Feb 2, 2018